2 news items
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
INCR
1 May 24
plans, its continued growth, the expected operations, financial results business strategy, competitive strengths, goals and expansion and growth
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
INCR
1 Apr 24
results business strategy, competitive strengths, goals and expansion and growth plans, expansion strategy to major markets worldwide, the impact
- Prev
- 1
- Next